fluorodeoxyglucose f18 has been researched along with Nasopharyngeal Carcinoma in 90 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 58 (64.44) | 24.3611 |
2020's | 32 (35.56) | 2.80 |
Authors | Studies |
---|---|
Chen, EN; Chen, WC; Liu, ZQ; OuYang, PY; Wu, YS; Xiao, SM; Xie, FY; Yang, SS; Zhang, BY; Zhang, J; Zhang, X | 1 |
Gong, X; Jin, H; Lin, Y; Marks, T; Shan, H; Wan, J; Wang, S; Wang, Y; Yang, Y; Yao, J; Zhang, F; Zhang, W | 1 |
Chen, H; Pang, Y; Shang, Q; Yu, Y; Zhao, L | 1 |
Feng, YL; Lu, SN; Wang, Y; Xian, WJ; Yang, M | 1 |
Chen, C; Chen, T; Fei, Z; Hu, Y; Huang, C; Li, L; Liang, Z; Liu, J; Qiu, X; Xie, S; Xu, T; You, Z; Zheng, Y | 1 |
Chen, Y; Fu, W; Liu, H; Yang, X | 1 |
Vardhanabhuti, V; Xie, C | 1 |
Chen, C; Fei, Z; Hu, Y; Huang, C; Li, L; Liang, Z; Liu, J; Qiu, X; Wu, H; Xie, S; Xu, T; Yi, L; You, Z; Zheng, Y | 1 |
Blandino, A; Brogna, A; Cacciola, A; Ferini, G; Lillo, S; Minutoli, F; Parisi, S; Pergolizzi, S; Tamburella, C | 1 |
Chen, D; Chen, W; Chen, Y; Lin, Z; Lou, Y; Song, L; Sun, J; Zhang, M | 1 |
Chen, M; Chen, WM; Chiang, CW; Shia, BC; Wu, SY; Yang, PC | 1 |
Chang, CC; Chi, YM; Liu, CT; Yen, WJ | 1 |
Chen, CY; Fan, W; Guo, ZX; He, Y; Li, A; Li, J; Lin, QG; Liu, ZQ; OuYang, PY; Peng, QH; Wu, YS; Xiao, SM; Xie, CM; Xie, FY; Xu, SK; Yang, SS; Yao, WY; Zhang, BY; Zhang, X | 1 |
Boldig, K; Montanarella, M; Natter, P; Ozdemir, S | 1 |
Chen, C; Chen, J; Ding, J; Fei, Z; Hong, H; Huang, C; Li, L; Liu, J; Qiu, X; Xu, T; Xu, Y | 1 |
Hu, C; Ou, X; Sun, C; Yan, W | 1 |
Cao, C; Chen, S; Chen, X; Fang, Y; Huang, S; Qiang, M; Tao, C; Wang, L; Xu, Y | 1 |
Lu, L; Lv, W; Wang, Q; Wu, Y; Xu, H; Yuan, Q; Zhang, H | 1 |
Hu, F; Huang, J; Lan, X; Li, C; Wu, B; Xu, Y; Yang, K; Yang, Y | 1 |
Ahn, MJ; Ahn, YC; Choi, JY; Kim, SJ; Moon, SH | 1 |
Cao, C; Chen, X; Huang, S; Qiang, M; Tao, C; Wang, L; Xu, Y | 1 |
Huang, R; Liu, Y; Qi, M; Su, M | 1 |
Bi, L; Feng, DD; Gu, B; Kim, J; Meng, M; Song, S; Xu, M | 1 |
Chen, C; Chen, J; Ding, J; Fei, Z; Hong, J; Huang, C; Li, Z; Lin, Y; Zhou, Q | 1 |
Chen, QY; Guo, SS; Li, XY; Liang, YJ; Liu, LT; Liu, SL; Mai, HQ; Sun, XS; Tang, LQ; Tang, QN; Wen, YF; Xie, HJ; Yan, JJ | 1 |
Chua, ML; Sun, Y; Supiot, S | 1 |
Chen, H; Chen, P; Fu, K; Liao, X; Lin, Q; Wang, Y; Zhao, L; Zhuang, Y; Zhuo, J | 1 |
Gu, B; Ma, G; Shi, L; Song, S; Yang, Z; Zhang, J; Zhang, Y | 1 |
Amthauer, H; Bauersachs, L; Beck, M; Budach, V; Ehrhardt, VH; Hajiyianni, M; Hartmann, V; Hofheinz, F; Kalinauskaite, G; Li, Y; Lin, Q; Rogasch, J; Stromberger, C; van den Hoff, J; Weingärtner, J; Zschaeck, S | 1 |
Chen, QY; Guo, SS; Jia, GD; Liu, LT; Liu, SL; Luo, DH; Mai, HQ; Sun, R; Sun, XS; Tang, LQ; Xie, HJ; Yu, YF | 1 |
Chen, QY; Fan, W; Guo, L; Guo, SS; Han, LJ; Li, JB; Li, XY; Liang, YJ; Lin, C; Lin, DF; Liu, LT; Liu, SL; Luo, DH; Lv, XF; Mai, HQ; Sun, R; Sun, XS; Tang, LQ; Tang, QN; Wen, YF; Xiao, BB; Yuan, L; Zhang, X | 1 |
Chen, QY; Fan, W; Guo, L; Guo, SS; Han, LJ; Li, JB; Li, XY; Liang, YJ; Lin, DF; Liu, LT; Liu, SL; Luo, DH; Lv, XF; Mai, HQ; Sun, R; Sun, XS; Tang, LQ; Tang, QN; Wen, YF; Xiao, BB; Yuan, L; Zhang, X | 1 |
Cao, C; Chen, X; Hu, Q; Hua, Y; Huang, S; Jiang, F; Jin, Q; Jin, T; Piao, Y; Xu, Y | 1 |
Feng, M; He, Q; Huang, Y; Jiang, Q; Lang, J; Xu, P; Yin, J | 1 |
Han, YQ; He, Q; Hu, Y; Li, Y; Liu, F; Liu, L; Luo, L; Ma, HZ; Mo, Y; Wang, H; Xi, XP; Xiao, F; Xiao, Q; Zhang, L | 1 |
Cheng, ZB; Jin, YN; Ma, J; Mo, HY; Sun, Y; Wang, SY; Yao, JJ; Zhang, F; Zhang, WJ; Zhou, GQ | 1 |
Chen, H; Chen, Y; He, S; Hong, S; Liang, S; Peng, P; Wang, Y; Xia, L; Yang, L | 1 |
Chen, L; Guo, R; Guo, Y; Li, WF; Lin, XP; Liu, LZ; Ma, J; Mao, YP; Peng, H; Sun, Y; Tang, LL; Tian, L; Zhang, X; Zhang, Y | 1 |
Chan, SC; Chang, JT; Chang, KP; Fan, KH; Hsu, CL; Huang, BS; Liao, CT; Lin, CY; Ng, SH; Wang, HM; Yeh, CH; Yen, TC; Yen-Ming, T | 1 |
Chen, W; Feng, Q; Jiang, J; Lu, L; Lv, W; Ma, J; Rahmim, A; Wang, Q; Yang, W; Yuan, Q | 1 |
Chan, AT; Chan, CM; Chan, KCA; Hui, EP; Kam, MK; King, A; Leung, SF; Li, L; Lo, YMD; Loong, H; Ma, B; Mo, F; Wang, K; Wong, A; Wong, SCC | 1 |
Cho, H; Choi, EC; Kim, H; Kim, SH; Koh, YW; Yun, M | 1 |
Chen, XY; Luo, QY; Zhang, GQ; Zhang, XY | 1 |
Chang, SK; Jeong, Y; Jung, IH; Kim, JS; Lee, SW | 1 |
Chan, SC; Chang, JT; Chang, KP; Chen, YH; Chu, SC; Hsu, CL; Liu, SH; Ng, SH; Wang, LY; Yen, TC | 1 |
Cao, C; Chen, X; Hu, Q; Niu, T; Xu, Y; Yang, P | 1 |
Chen, C; Chen, T; Fei, Z; Huang, Y; Li, L; Li, Y; Qiu, X | 1 |
Dong, ZR; Li, T; Zhi, XT | 1 |
Julian, J; Levine, MN | 1 |
Cao, KJ; Cao, Y; Chen, MY; Chen, QY; Fan, W; Guo, L; Guo, X; Hua, YJ; Huang, PY; Li, J; Lin, XP; Liu, H; Liu, LZ; Luo, DH; Lv, X; Mai, HQ; Mo, HY; Mo, YX; Qian, CN; Qiu, F; Sun, R; Tang, LQ; Wang, L; Xiang, YQ; Zeng, MS; Zhang, L; Zhang, X; Zhao, C; Zou, RH | 1 |
Khoo, JB; Tan, NC; Teo, PT | 1 |
Hu, C; Hu, S; Li, D; Pan, H; Shi, W; Yang, Z; Yao, Z; Zhang, Y; Zhu, B | 1 |
Han, J; Hu, S; Ke, S; Lei, G; Li, C; Liu, Z; Lu, M; Ran, H; Wang, W; Yang, G; Zhang, F; Zhang, T; Zhang, W; Zhang, Y; Zou, C | 1 |
Kang, H; Marcus, C; Mohandas, A; Subramaniam, RM; Truong, MT | 1 |
Hu, C; Shi, Q; Yang, Z; Zhang, Y | 1 |
Cho, KS; Hong, SL; Kim, SJ; Lee, SH; Roh, HJ; Yoon, YH | 1 |
Deng, H; Jia, Z; Li, J; Shen, G; Wang, Q; Zhang, W | 1 |
Cai, L; Chen, Y; Huang, Z; Wu, J; Zhang, Y | 1 |
Goh, BC; Khor, LK; Loh, KS; Loi, HY; Lu, SJ; Sinha, AK; Tong, KT | 2 |
Chen, QY; Guo, SS; Guo, X; Li, PJ; Liu, LT; Luo, DH; Mai, DM; Mai, HQ; Mo, HY; Qian, CN; Shen, T; Tang, LQ; Zeng, MS | 1 |
Chen, TT; Chiu, CF; Hsieh, CY; Hsieh, TC; Hua, CH; Lin, CC; Lin, CY; Sher, YP; Yang, TY; Yeh, SP | 1 |
Deng, H; Jia, Z; Shen, G; Wang, Q; Zhang, W; Zhou, L | 1 |
Chen, L; Hu, W; Wang, Y; Wei, G; Xian, W; Zhang, N | 1 |
Huang, B; Khong, PL; Kwong, DL; Lai, V; Wong, CY | 1 |
Chen, W; Feng, Q; Huang, M; Jiang, J; Wang, Q; Wu, H; Wu, Y; Yang, W; Zhao, J | 1 |
Al Tamimi, AS; Ng, DC; Osmany, S; Zaheer, S | 1 |
Cao, KJ; Chen, QY; Chen, WH; Fan, W; Guo, L; Guo, SS; Guo, X; Liu, LT; Mai, HQ; Qian, CN; Tang, LQ; Xie, D; Zeng, MS; Zhang, L; Zhang, X; Zhao, C | 1 |
Cai, H; Li, L; Shen, G; Zhang, W; Zhou, H; Zhou, Y | 1 |
Pei, S; Wei, J; Zhu, X | 1 |
Cho, BC; Keum, KC; Kim, KH; Lee, CG; Lee, J; Roh, YH; Yoon, HI; Yun, M | 1 |
Chan, HY; Ho, JC; Lee, EY; Tsoi, A; Wong, MP | 1 |
Chen, YZ; Li, WF; Ou, RY; Wang, JM; Wang, JY; Xu, YS; Zhao, L; Zheng, XW | 1 |
Chen, L; Li, WF; Liu, Q; Ma, J; Mao, YP; Peng, H; Sun, Y; Zhang, Y; Zhou, GQ | 1 |
Bray, V; Chicco, A; Forstner, D; Fowler, A; Holloway, L; Lee, M; Lin, P; Min, M; Xuan, W | 1 |
Chan, SC; Chang, KP; Fang, YD; Hsu, CL; Liao, CT; Ng, SH; Tsang, NM; Yen, TC | 1 |
Ahn, MJ; Ahn, YC; Cho, YS; Choi, JY; Kim, BT; Lee, KH; Moon, SH; Son, YI | 1 |
Li, H; Liao, G; Lin, J; Wang, B; Xie, G; Yan, M; Yuan, Y | 1 |
Chen, HC; Chen, MK; Hung, GU; Lee, HS; Wu, IS; You, WC | 1 |
Chan, SC; Chang, CJ; Chang, JT; Liao, CT; Lin, CY; Lin, SY; Ng, SH; Wang, HM; Yen, TC | 1 |
Chan, WK; Huang, B; Khong, PL; Kwong, DL; Yeung, DW | 1 |
Hsieh, TC; Hsu, CN; Kao, CH; Sun, SS; Wu, YC; Yang, CF; Yen, KY | 1 |
Chan, SC; Chang, KP; Chung, MJ; Hsu, CL; Liao, CT; Lo, CW; Ng, SH; Tsang, NM; Wang, HM; Yen, TC | 1 |
Bengua, G; Hasegawa, M; Ishikawa, M; Katoh, N; Onimaru, R; Shiga, T; Shimizu, S; Shirato, H; Tamaki, N; Yasuda, K | 1 |
Lin, JC; Lin, PJ; Wang, WY | 1 |
Cheuk, DK; Hossain, M; Krasin, MJ; Naik, M; Rodriguez-Galindo, C; Sabin, ND; Shulkin, BL; Wozniak, A | 1 |
Chen, S; Lin, Q; Sun, L; Wu, H; Yang, R | 1 |
Chan, T; Chan, WK; Huang, B; Khong, PL; Kwong, DL | 1 |
Li, S; Li, X; Liang, B; Lin, S; Liu, X; Lu, J; Peng, X; Wu, H; Yu, L | 1 |
Drage, MG; Haddad, RI; Lichtman, AH; Shah, SM | 1 |
9 review(s) available for fluorodeoxyglucose f18 and Nasopharyngeal Carcinoma
Article | Year |
---|---|
PET/CT: Nasopharyngeal Cancers.
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography | 2022 |
Prognostic value of pretreatment 18F-FDG PET-CT for nasopharyngeal carcinoma patients.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Observational Studies as Topic; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals | 2017 |
Imaging appearances for recurrent nasopharyngeal carcinoma and post-salvage nasopharyngectomy.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Nasopharynx; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
FDG PET/CT in the management of nasopharyngeal carcinoma.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2014 |
Meta-analysis of diagnostic value of 18F-FDG PET or PET/CT for detecting lymph node and distant metastases in patients with nasopharyngeal carcinoma.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed | 2014 |
[Meta-analysis of PET/CT for diagnosis of residual/recurrent nasopharyngeal carcinoma].
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
18F-FDG PET/CT for the Diagnosis of Residual or Recurrent Nasopharyngeal Carcinoma After Radiotherapy: A Metaanalysis.
Topics: Adolescent; Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2016 |
Comparison of 18F-FDG PET/CT, MRI and SPECT in the diagnosis of local residual/recurrent nasopharyngeal carcinoma: A meta-analysis.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2016 |
Prognostic value of 18F-FDG-PET/CT in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis.
Topics: Carcinoma; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Publication Bias; ROC Curve | 2017 |
6 trial(s) available for fluorodeoxyglucose f18 and Nasopharyngeal Carcinoma
Article | Year |
---|---|
The prognostic value of radiomic features from pre- and post-treatment
Topics: Fluorodeoxyglucose F18; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies | 2023 |
Prospective evaluation of plasma Epstein-Barr virus DNA clearance and fluorodeoxyglucose positron emission scan in assessing early response to chemotherapy in patients with advanced or recurrent nasopharyngeal carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; DNA, Viral; Drug Monitoring; Epstein-Barr Virus Infections; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Herpesvirus 4, Human; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Response Evaluation Criteria in Solid Tumors; Time Factors; Treatment Outcome; Tumor Burden; Viral Load | 2018 |
Primary tumor volume measured by FDG PET and CT in nasopharyngeal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed; Tumor Burden | 2011 |
Prognostic significance of 18F-FDG PET parameters and plasma Epstein-Barr virus DNA load in patients with nasopharyngeal carcinoma.
Topics: Biomarkers, Tumor; Carcinoma; DNA, Viral; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Treatment Outcome; Viral Load | 2012 |
PET/CT for staging and follow-up of pediatric nasopharyngeal carcinoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Biological response of nasopharyngeal carcinoma to radiation therapy: a pilot study using serial 18F-FDG PET/CT scans.
Topics: Adolescent; Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Pilot Projects; Positron-Emission Tomography; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2012 |
75 other study(ies) available for fluorodeoxyglucose f18 and Nasopharyngeal Carcinoma
Article | Year |
---|---|
Benefit of [18F]-FDG PET/CT for treatment-naïve nasopharyngeal carcinoma.
Topics: Epstein-Barr Virus Infections; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Lymph Nodes; Lymphatic Metastasis; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sensitivity and Specificity | 2022 |
The Role of Pretreatment
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Nomograms; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Young Adult | 2021 |
68Ga-FAPI PET/CT Distinguishes the Reactive Lymph Nodes From Tumor Metastatic Lymph Nodes in a Patient With Nasopharyngeal Carcinoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines | 2022 |
Usefulness of
Topics: Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphocyte Count; Male; Middle Aged; Nasopharyngeal Carcinoma; Platelet Count; Positron Emission Tomography Computed Tomography; Prognosis; Progression-Free Survival; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; ROC Curve | 2022 |
Selectively recommend
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; DNA, Viral; Endemic Diseases; Epstein-Barr Virus Infections; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Young Adult | 2021 |
Increased 68Ga-FAPI Uptake in Avascular Necrosis of Femoral Head in a Patient With Nasopharyngeal Carcinoma.
Topics: Aged; Femur Head; Femur Head Necrosis; Fluorodeoxyglucose F18; Humans; Male; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines | 2022 |
Reflecting on the utility of standardized uptake values on
Topics: Fluorodeoxyglucose F18; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2022 |
Intensity-modulated radiotherapy does not induce volumetric changes of the Bichat fat pad in nasopharyngeal cancer.
Topics: Adipose Tissue; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Retrospective Studies | 2022 |
The prognostic value of the ratio of standard uptake value of lymph node to primary tumor before treatment of locally advanced nasopharyngeal carcinoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2023 |
Survival effect of pretreatment FDG-PET-CT on nasopharyngeal cancer.
Topics: Cohort Studies; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Skeletal scintigraphy as an important complement for detecting bone metastasis from nasopharyngeal carcinoma.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals | 2022 |
Benefit of [
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Salvage Therapy; Sensitivity and Specificity | 2023 |
18 F-FDG PET/CT Findings of Leptomeningeal Metastasis in Nasopharyngeal Carcinoma.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Meningeal Carcinomatosis; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
PET/CT standardized uptake value and EGFR expression predicts treatment failure in nasopharyngeal carcinoma.
Topics: ErbB Receptors; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Treatment Failure | 2023 |
Prognostic value of pre-treatment FDG PET/CT SUVmax for metastatic lesions in de novo metastatic nasopharyngeal carcinoma following chemotherapy and locoregional radiotherapy.
Topics: Fluorodeoxyglucose F18; Humans; Male; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2023 |
Assessment of bone lesions with 18 F-FDG PET/MRI in patients with nasopharyngeal carcinoma.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2023 |
Multimodality radiomics analysis based on [
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2023 |
Evaluation of 11 C-Choline PET/CT for T Staging and Tumor Volume Delineation in Nasopharyngeal Cancer Patients in Comparison to 18 F-FDG PET/CT.
Topics: Choline; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tumor Burden | 2023 |
The impact of the COVID-19 pandemic on nasopharyngeal carcinoma extent at FDG PET/MR staging: The NPCOVIPET study.
Topics: COVID-19; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Pandemics; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2023 |
Primary Hepatocellular Carcinoma Revealed on 68 Ga-DOTATATE in a Patient With Nasopharyngeal Carcinoma.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prospective Studies | 2023 |
Multi-task deep learning-based radiomic nomogram for prognostic prediction in locoregionally advanced nasopharyngeal carcinoma.
Topics: Deep Learning; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Nomograms; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2023 |
Radiomics-clinical nomogram based on pretreatment 18F-FDG PET-CT radiomics features for individualized prediction of local failure in nasopharyngeal carcinoma.
Topics: Fluorodeoxyglucose F18; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Nomograms; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2023 |
Maximal standard uptake values of
Topics: Adult; Aged; DNA, Viral; Epstein-Barr Virus Infections; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; ROC Curve | 2019 |
Advances in nasopharyngeal carcinoma
Topics: Age Factors; Artificial Intelligence; Big Data; Chemoradiotherapy; Fluorodeoxyglucose F18; Geography, Medical; Humans; Nasopharyngeal Carcinoma; Organs at Risk; Positron-Emission Tomography; Radiation Exposure; Radiopharmaceuticals; Radiotherapy Dosage; Software | 2019 |
Usefulness of [
Topics: B7-H1 Antigen; Epstein-Barr Virus Infections; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2020 |
Establishment and validation of a nomogram with intratumoral heterogeneity derived from
Topics: Adolescent; Adult; Aged; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Middle Aged; Nasopharyngeal Carcinoma; Neoplasm Staging; Nomograms; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Recurrence; Reproducibility of Results; Young Adult | 2020 |
Prognostic value of baseline [18F]-fluorodeoxyglucose positron emission tomography parameters MTV, TLG and asphericity in an international multicenter cohort of nasopharyngeal carcinoma patients.
Topics: Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; International Agencies; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tumor Burden | 2020 |
Identifying optimal candidates for induction chemotherapy among stage II-IVa nasopharyngeal carcinoma based on pretreatment Epstein-Barr virus DNA and nodal maximal standard uptake values of [
Topics: Clinical Decision-Making; Disease Progression; DNA, Viral; Epstein-Barr Virus Infections; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Induction Chemotherapy; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Progression-Free Survival; Radiopharmaceuticals; Retrospective Studies; Time Factors | 2020 |
Low value of whole-body dual-modality [18f]fluorodeoxyglucose positron emission tomography/computed tomography in primary staging of stage I-II nasopharyngeal carcinoma: a nest case-control study.
Topics: Case-Control Studies; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2021 |
Nomogram for the prediction of primary distant metastasis of nasopharyngeal carcinoma to guide individualized application of FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Nomograms; Positron Emission Tomography Computed Tomography; Prognosis | 2021 |
Detection and staging of recurrent or metastatic nasopharyngeal carcinoma in the era of FDG PET/MR.
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2022 |
PET/CT-guided dose-painting versus CT-based intensity modulated radiation therapy in locoregional advanced nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2017 |
Prognostic value of primary gross tumor volume and standardized uptake value of
Topics: Adult; Aged; Carcinoma; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Tomography, X-Ray Computed; Tumor Burden | 2017 |
Development and external validation of nomograms to predict the risk of skeletal metastasis at the time of diagnosis and skeletal metastasis-free survival in nasopharyngeal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Bone Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Nomograms; Positron Emission Tomography Computed Tomography; Prognosis; Reproducibility of Results; Retrospective Studies; Young Adult | 2017 |
Significant value of
Topics: Adolescent; Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neck; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiotherapy, Intensity-Modulated; ROC Curve; Treatment Outcome; Young Adult | 2017 |
Clinical utility of simultaneous whole-body
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Carcinoma; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2018 |
Robustness versus disease differentiation when varying parameter settings in radiomics features: application to nasopharyngeal PET/CT.
Topics: Adolescent; Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Nasopharyngitis; Positron Emission Tomography Computed Tomography; Radiometry; ROC Curve; Young Adult | 2018 |
Lymph Node With the Highest FDG Uptake Predicts Distant Metastasis-Free Survival in Patients With Locally Advanced Nasopharyngeal Carcinoma.
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Survival Analysis | 2018 |
Diffuse Liver Metastasis From Nasopharyngeal Carcinoma Found by 18F-FDG PET/CT Scans.
Topics: Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography | 2018 |
Clinical significance of the post-radiotherapy
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Time Factors; Young Adult | 2019 |
Value of early evaluation of treatment response using
Topics: Adult; DNA, Viral; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Male; Middle Aged; Multivariate Analysis; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Retrospective Studies; Survival Rate; Time Factors; Treatment Outcome | 2019 |
Feasibility of multiparametric imaging with PET/MR in nasopharyngeal carcinoma: A pilot study.
Topics: Adult; Aged; Diffusion Magnetic Resonance Imaging; Feasibility Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Pilot Projects; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2019 |
Metabolic tumor volume and conformal radiotherapy based on prognostic PET/CT for treatment of nasopharyngeal carcinoma.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Conformal; Retrospective Studies; Survival Analysis; Tumor Burden; Young Adult | 2019 |
A Rapidly Progressing Polycystic Liver Disease?
Topics: Biopsy; Cysts; Diagnosis, Differential; Disease Progression; Fluorodeoxyglucose F18; Humans; Liver; Liver Diseases; Liver Neoplasms; Lymph Nodes; Male; Middle Aged; Nasal Cavity; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Nasopharynx; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Time Factors | 2020 |
Selective application of a test based on risk: using limited resources wisely.
Topics: Carcinoma; DNA, Viral; Epstein-Barr Virus Infections; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Male; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Radionuclide Imaging | 2013 |
Prospective study of tailoring whole-body dual-modality [18F]fluorodeoxyglucose positron emission tomography/computed tomography with plasma Epstein-Barr virus DNA for detecting distant metastasis in endemic nasopharyngeal carcinoma at initial staging.
Topics: Carcinoma; DNA, Viral; Epstein-Barr Virus Infections; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Risk Factors; Tomography, X-Ray Computed | 2013 |
Is 18F-FDG PET/CT more reliable than 99mTc-MDP planar bone scintigraphy in detecting bone metastasis in nasopharyngeal carcinoma?
Topics: Adult; Aged; Bone Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Young Adult | 2014 |
Multi-modality imaging to determine the cellular heterogeneity of nasopharyngeal carcinoma components.
Topics: Animals; Carcinoma; Cell Line, Tumor; Contrast Media; Fluorodeoxyglucose F18; Heterografts; Humans; Mice; Mice, Nude; Microscopy, Confocal; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Radiopharmaceuticals | 2014 |
Adding maximum standard uptake value of primary lesion and lymph nodes in 18F-fluorodeoxyglucose PET helps predict distant metastasis in patients with nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Carcinoma; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2014 |
Prognostic value of metabolic tumor volume as measured by fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in nasopharyngeal carcinoma.
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden; Young Adult | 2014 |
Nasopharyngeal tuberculosis mimicking nasopharyngeal carcinoma on (18)F-FDG PET/CT in a young patient.
Topics: Adult; Carcinoma; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tuberculosis, Laryngeal | 2015 |
Correlation between (68)Ga-DOTA-NOC PET/CT and (18)F-FDG PET/CT in EBV-positive undifferentiated nasopharyngeal carcinoma.
Topics: Adult; Carcinoma; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Different prognostic values of plasma Epstein-Barr virus DNA and maximal standardized uptake value of 18F-FDG PET/CT for nasopharyngeal carcinoma patients with recurrence.
Topics: Adolescent; Adult; Aged; Carcinoma; Child; DNA, Viral; Epstein-Barr Virus Infections; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed | 2015 |
[18F]-Fluorodeoxyglucose Positron Emission Tomography Standardized Uptake Value as a Predictor of Adjuvant Chemotherapy Benefits in Patients With Nasopharyngeal Carcinoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiography; Survival Rate | 2015 |
[Value of FDG PET-CT associated with pathology in diagnosing residual tumor in patients with nasopharyngeal carcinoma after radiotherapy].
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Prognostic Value of (18)F-FDG PET-CT in Nasopharyngeal Carcinoma: Is Dynamic Scanning Helpful?
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiography | 2015 |
Variability of Gross Tumor Volume in Nasopharyngeal Carcinoma Using 11C-Choline and 18F-FDG PET/CT.
Topics: Carbon Radioisotopes; Carcinoma; Choline; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2015 |
(68)Ga-DOTA-peptide: A novel molecular biomarker for nasopharyngeal carcinoma.
Topics: Adult; Aged; Biomarkers; Biomarkers, Tumor; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prospective Studies; Receptors, Somatostatin | 2016 |
The incidence and sites of Nasopharyngeal carcinoma (NPC) metastases on FDG PET/CT scans.
Topics: Adult; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Incidence; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Singapore; Tomography, X-Ray Computed; Whole Body Imaging | 2015 |
Combining plasma Epstein-Barr virus DNA and nodal maximal standard uptake values of 18F-fluoro-2-deoxy-D-glucose positron emission tomography improved prognostic stratification to predict distant metastasis for locoregionally advanced nasopharyngeal carci
Topics: Carcinoma; Disease Progression; Disease-Free Survival; DNA, Viral; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Kaplan-Meier Estimate; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Viral Load | 2015 |
The Clinical Usefulness of (18)F-Fluorodeoxyglucose Positron Emission Tomography (PET) to Predict Oncologic Outcomes and PET-Based Radiotherapeutic Considerations in Locally Advanced Nasopharyngeal Carcinoma.
Topics: Adolescent; Adult; Aged; Carcinoma; Chemoradiotherapy; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Induction Chemotherapy; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radiation Dosage; Radiopharmaceuticals; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Retrospective Studies; Treatment Failure; Tumor Burden; Young Adult | 2016 |
Utility of 18F-FDG PET/CT in the assessment of lymphoepithelioma-like carcinoma.
Topics: Adult; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Recurrence; Treatment Outcome | 2016 |
Evaluation of Time-Phase Effect on 18F-FDG PET/CT Delineation Methods for Treatment Planning of Nasopharyngeal Carcinoma.
Topics: Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tumor Burden | 2016 |
Establishment of an integrated model incorporating standardised uptake value and N-classification for predicting metastasis in nasopharyngeal carcinoma.
Topics: Adult; Aged; Carcinoma; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Models, Theoretical; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2016 |
Prognostic utility of (18)F-FDG PET-CT performed prior to and during primary radiotherapy for nasopharyngeal carcinoma: Index node is a useful prognostic imaging biomarker site.
Topics: Adult; Aged; Biomarkers; Carcinoma; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals | 2016 |
Tumor heterogeneity measured on F-18 fluorodeoxyglucose positron emission tomography/computed tomography combined with plasma Epstein-Barr Virus load predicts prognosis in patients with primary nasopharyngeal carcinoma.
Topics: Carcinoma; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Treatment Outcome; Viral Load | 2017 |
Value of
Topics: Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Clinical utility of 18F-FDG PET parameters in patients with advanced nasopharyngeal carcinoma: predictive role for different survival endpoints and impact on prognostic stratification.
Topics: Aged; Aged, 80 and over; Carcinoma; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Survival Analysis; Treatment Outcome; Tumor Burden | 2011 |
Prognostic impact of standardized uptake value of F-18 FDG PET/CT in nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Carcinoma; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Reference Standards; Tomography, X-Ray Computed | 2011 |
Lower neck neurilemmoma can masquerade as lymph node metastasis on FDG PET/CT in patient with nasopharyngeal carcinoma.
Topics: Carcinoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neurilemmoma; Positron-Emission Tomography; Tomography, X-Ray Computed; Ultrasonography | 2011 |
A new brain positron emission tomography scanner with semiconductor detectors for target volume delineation and radiotherapy treatment planning in patients with nasopharyngeal carcinoma.
Topics: Adult; Aged; Bismuth; Brain; Carcinoma; Female; Fluorodeoxyglucose F18; Germanium; Humans; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Circulating EBV DNA and ¹⁸F-FDG PET scan in the diagnosis and monitoring of nasopharyngeal carcinoma.
Topics: Carcinoma; DNA, Viral; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2012 |
Nasopharyngeal carcinoma: investigation of intratumoral heterogeneity with FDG PET/CT.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Cell Differentiation; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Young Adult | 2012 |
[Efficiency comparison between PET/CT and conventional work-up for evaluating distant metastasis of nasopharyngeal carcinoma].
Topics: Aged; Carcinoma; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2012 |
Metastatic human papillomavirus-positive nasopharyngeal carcinoma with an unusual pattern of aggressive hematogenous spread.
Topics: Alphapapillomavirus; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biomarkers, Tumor; Carboplatin; Carcinoma; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Diagnosis, Differential; Drug Administration Schedule; Fatal Outcome; Fluorodeoxyglucose F18; Fluorouracil; Heart Failure; Humans; Hypertension, Pulmonary; Hypoxia; Immunohistochemistry; Laryngoscopy; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Papillomavirus Infections; Positron-Emission Tomography; Pulmonary Artery; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Randomized Controlled Trials as Topic; Thrombophilia; Tomography, X-Ray Computed; Vascular Neoplasms | 2012 |